I am no expert but I would suggest that the market is large enough for multiple solutions - our focus is not LSD based and thus should/could/would be able to be focused on alternative cures to those under Ph 2b trials
Just my thoughts
- Forums
- ASX - By Stock
- IHL
- Industry news
Industry news, page-508
-
- There are more pages in this discussion • 391 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)